Executive Editor
RheumNow
Dallas, Texas, United States
John J. Cush, MD, is the executive editor of RheumNow.com - a news, information and education network dedicated to Rheumatologists.
He is a private practice rheumatologist and holds an academic appointment as a clinical professor of internal medicine at the TCU Burnett School of Medicine in Fort Worth, Texas.
Dr. Cush received his medical degree from St. George’s University School of Medicine in Grenada, West Indies. He completed his rheumatology training at The University of Texas Health Science Center and Parkland Memorial Hospital in Dallas. Dr. Cush’s research has focused on translational immunology and novel drug development.
He is a clinician, researcher, and medical educator with career interests in rheumatoid arthritis, spondyloarthritis, Still’s disease, drug safety, biologic and novel therapies, pregnancy and spondyloarthritis.
He has published over 150 journal articles, numerous textbook chapters and has co-authored the medical textbooks, Rheumatology: Diagnosis and Therapeutics (2nd edition, 2005), Rheumatoid Arthritis: Diagnosis and Treatment (4th edition, 2014) and the free, on-line textbook RheumaKnowledgy.com (2014). He written the chapter on “The evaluation of the musculoskeletal complaint” in Harrisons Principals of Internal Medicine from 1987 (11th edition) to the current 22nd edition, released in 2025.
Your Knowledgebase is Obsolete – Fix it with AI & Virtual Learning!
Monday, October 27, 2025
10:00 AM - 11:00 AM Central Time
Disclosure(s): Sanofi: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing)
Monday, October 27, 2025
10:00 AM - 10:05 AM Central Time
Disclosure(s): Sanofi: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing)
Social Media & Virtual Learning
Monday, October 27, 2025
10:25 AM - 10:35 AM Central Time
Disclosure(s): Sanofi: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing)
Monday, October 27, 2025
10:35 AM - 10:45 AM Central Time
Disclosure(s): Sanofi: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing)
Monday, October 27, 2025
10:45 AM - 10:55 AM Central Time
Disclosure(s): Sanofi: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing)